Expediting drug development & targeting early-stage disease: how is clinical trial design in immuno-oncology evolving?
Immuno-Oncology Insights 2022; 3(1), 155–162
10.18609/ioi.2022.017
Published: 27 March
Roisin McGuigan, Commissioning Editor, Bioinsights, speaks to Patrick Forde, Director, Thoracic Oncology Clinical Research Program, Associate Professor of Oncology, Johns Hopkins